Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C26H28F3N3O4 |
| Molecular Weight | 503.5134 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC[C@H](OC1=CC(C)=C(N2C=C(C=N2)C(F)(F)F)C(C)=C1)C3=CC=C(C=C3)C(=O)NCCC(O)=O
InChI
InChIKey=IBDYYOQKQCCSDP-QFIPXVFZSA-N
InChI=1S/C26H28F3N3O4/c1-4-5-22(18-6-8-19(9-7-18)25(35)30-11-10-23(33)34)36-21-12-16(2)24(17(3)13-21)32-15-20(14-31-32)26(27,28)29/h6-9,12-15,22H,4-5,10-11H2,1-3H3,(H,30,35)(H,33,34)/t22-/m0/s1
| Molecular Formula | C26H28F3N3O4 |
| Molecular Weight | 503.5134 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Efficacy and safety of the glucagon receptor antagonist PF-06291874: A 12-week, randomized, dose-response study in patients with type 2 diabetes mellitus on background metformin therapy. | 2018-11 |
|
| A 4-week study assessing the pharmacokinetics, pharmacodynamics, safety, and tolerability of the glucagon receptor antagonist PF-06291874 administered as monotherapy in subjects with type 2 diabetes mellitus. | 2017-04 |
|
| Effects of multiple ascending doses of the glucagon receptor antagonist PF-06291874 in patients with type 2 diabetes mellitus. | 2016-08 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 20:54:20 GMT 2025
by
admin
on
Mon Mar 31 20:54:20 GMT 2025
|
| Record UNII |
CGY4I8F278
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Code | English | ||
|
Preferred Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
1393124-08-7
Created by
admin on Mon Mar 31 20:54:20 GMT 2025 , Edited by admin on Mon Mar 31 20:54:20 GMT 2025
|
PRIMARY | |||
|
60151939
Created by
admin on Mon Mar 31 20:54:20 GMT 2025 , Edited by admin on Mon Mar 31 20:54:20 GMT 2025
|
PRIMARY | |||
|
DB15065
Created by
admin on Mon Mar 31 20:54:20 GMT 2025 , Edited by admin on Mon Mar 31 20:54:20 GMT 2025
|
PRIMARY | |||
|
CHEMBL3544946
Created by
admin on Mon Mar 31 20:54:20 GMT 2025 , Edited by admin on Mon Mar 31 20:54:20 GMT 2025
|
PRIMARY | |||
|
CGY4I8F278
Created by
admin on Mon Mar 31 20:54:20 GMT 2025 , Edited by admin on Mon Mar 31 20:54:20 GMT 2025
|
PRIMARY | |||
|
100000182683
Created by
admin on Mon Mar 31 20:54:20 GMT 2025 , Edited by admin on Mon Mar 31 20:54:20 GMT 2025
|
PRIMARY |